PH vs EMR Stock Comparison: AI Score, Valuation, Performance and Upside
PH is the world leader in motion and control technologies with broad industrial and aerospace exposure, while EMR has been transforming into a more focused process automation and intelligent software company. Both are large-cap industrials but with distinct product portfolios and strategic directions.
PH vs EMR compares two diversified industrial technology leaders: Parker Hannifin's broad motion-and-control franchise versus Emerson's focused transformation into a process automation and industrial software platform.
PH holds the edge across 3 of 5 key metrics in this comparison. PH has delivered stronger 1-year price return (+24.86% vs +13.65%), though EMR has the better forward P/E setup (21.42x vs 25.39x for PH). On fundamentals, PH is growing revenue faster (9.80%), while EMR maintains the higher operating margin (26.92%) — a classic growth-versus-profitability split. Analyst consensus implies meaningfully more upside for PH (+16.68%) than for EMR (+10.72%).
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- Want exposure to the world's largest motion and control technology portfolio
- Value Parker's aerospace segment as a higher-margin, long-cycle revenue stabilizer
- Believe the Win Strategy will continue driving margin improvement
- Want exposure to process automation and intelligent control software for critical industries
- Believe Emerson's portfolio transformation toward software will drive higher long-term margins
- See value in EMR's sticky, high-switching-cost process automation customer relationships
| Metric | PH | EMR |
|---|---|---|
| AI scorei | 62.6 | 52.3 |
| AI ranki | #114 | #401 |
| Latest closei | $943.54 | $149.92 |
| 1M returni | -7.79% | -4.87% |
| 6M returni | +5.49% | +16.99% |
| 1Y returni | +24.86% | +13.65% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | PH | EMR |
|---|---|---|
| 1Y ago | $12.49K (+24.9%) started 2025-09-19 | $11.33K (+13.3%) started 2025-09-19 |
| 5Y ago | $36.84K (+268.4%) started 2021-09-20 | $18.62K (+86.2%) started 2021-09-20 |
| 10Y ago | $102.63K (+926.3%) started 2016-09-19 | $47.1K (+371.0%) started 2016-09-19 |
Hypothetical — past performance does not guarantee future results.
| Metric | PH | EMR |
|---|---|---|
| Market capi | $125.42B | $86.56B |
| Trailing P/Ei | 34.96 | 34.03 |
| Forward P/Ei | 25.39 | 21.42 |
| Price/Salesi | N/A | N/A |
| EV/Revenuei | 6.22 | 5.27 |
| Analyst targeti | $1,160.95 | $171.81 |
| Target upsidei | +16.68% | +10.72% |
| Metric | PH | EMR |
|---|---|---|
| Revenue growthi | 9.80% | 7.00% |
| Earnings growthi | 19.30% | 23.00% |
| EPS growthi | +19.30% | +23.00% |
| FCF margini | +13.78% | +19.89% |
| Operating margini | 23.46% | 26.92% |
| Profit margini | 16.97% | 13.83% |
| ROIC proxyi | 25.08% | 12.80% |
| Return on equityi | 25.08% | 12.80% |
| Dividend yieldi | 0.80% | 1.43% |
| Payout ratioi | 25.98% | 47.98% |
| Dividend growth streaki | No increase yet | No increase yet |
| Betai | 1.13 | 1.24 |
| Debt/equityi | 56.66 | 67.68 |
| Current ratioi | 1.26 | 0.90 |
| Quick ratioi | 0.67 | 0.62 |
Over the past year, PH and EMR have moved moderately in the same direction (correlation of 0.57), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | PH | EMR |
|---|---|---|---|
| 1Y | Growthi | +24.86% | +13.28% |
| CAGRi | +24.94% | +13.32% | |
| Volatilityi | 26.44% | 31.93% | |
| Sharpe ratioi | 0.81 | 0.41 | |
| Sortino ratioi | 1.26 | 0.59 | |
| Max drawdowni | 19.52% | 23.74% | |
| Current drawdowni | 12.14% | 8.80% | |
| Avg drawdowni | 5.40% | 8.02% | |
| Ulcer Indexi | 7.50% | 9.97% | |
| Max daily dropi | 4.32% | 6.26% | |
| Max wkly dropi | 10.94% | 8.22% | |
| 5Y | Growthi | +249.19% | +71.45% |
| CAGRi | +28.44% | +11.39% | |
| Volatilityi | 28.88% | 27.76% | |
| Sharpe ratioi | 0.86 | 0.37 | |
| Sortino ratioi | 1.29 | 0.53 | |
| Max drawdowni | 28.64% | 29.61% | |
| Current drawdowni | 12.14% | 8.80% | |
| Avg drawdowni | 6.80% | 8.46% | |
| Ulcer Indexi | 9.48% | 10.40% | |
| Max daily dropi | 11.49% | 8.65% | |
| Max wkly dropi | 14.00% | 15.00% | |
| 10Y | Growthi | +785.45% | +266.68% |
| CAGRi | +24.37% | +13.88% | |
| Volatilityi | 31.73% | 29.28% | |
| Sharpe ratioi | 0.71 | 0.44 | |
| Sortino ratioi | 1.04 | 0.62 | |
| Max drawdowni | 54.68% | 50.77% | |
| Current drawdowni | 12.14% | 8.80% | |
| Avg drawdowni | 8.46% | 9.23% | |
| Ulcer Indexi | 11.98% | 11.96% | |
| Max daily dropi | 16.69% | 18.96% | |
| Max wkly dropi | 30.59% | 28.66% |
| Category | PH | EMR |
|---|---|---|
| Company | Parker Hannifin Corporation | Emerson Electric Co. |
| Sector | Industrials | Industrials |
| Industry | Specialty Industrial Machinery | Specialty Industrial Machinery |
| Core business | Parker Hannifin is the world's leading diversified manufacturer of motion and control technologies, providing hydraulic, pneumatic, electromechanical, and filtration systems for industrial, aerospace, and mobile equipment applications. | Emerson Electric provides automation, measurement, and control solutions for process industries including oil and gas, chemical, power, and life sciences, following a significant portfolio transformation that divested its climate technologies and tools businesses. |
| Investor focus | Investors track Parker's organic revenue growth across its industrial and aerospace segments, operating margin improvement through its Win Strategy initiatives, and free cash flow conversion. | Investors track Emerson's software-and-control automation growth in process industries, operating margin expansion, and the integration of acquired software companies to build its industrial software platform. |
- World leader in motion and control technologies with one of the broadest product portfolios in industrials
- Aerospace segment provides higher-margin, long-cycle revenue diversification from more cyclical industrial business
- Win Strategy management framework has driven consistent margin improvement over time
- Leading position in process automation and measurement for critical industries like energy, chemicals, and life sciences
- Ongoing portfolio transformation toward higher-margin software and intelligent automation solutions
- Process automation end markets are sticky due to high integration and switching costs
- Industrial segment revenue is cyclically sensitive to global manufacturing and capital spending activity
- Large recent acquisitions (Meggitt) carry integration risk and have elevated leverage
- Hydraulics market faces long-term secular pressure from electrification trends
- Portfolio transformation is still in progress, creating near-term revenue complexity
- Energy and industrial capex cycles drive demand for process automation investment
- Competition from Honeywell, ABB, and Siemens in the process automation and control market
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.